Dong et al. [13] analyzed the diagnostic value of CA19-9, CA 242, and serum peripherin (POSTN) for pancreatic cancer and finally found that CA19-9 and CA 242 combined with POSTN detection was a potential serum marker for the diagnosis of early pancreatic cancer. This evidence concerns the gene PRPH and familial pancreatic carcinoma.